Science
Mechanism of Action
This ingredient operates by demonstrating anti-inflammatory and antioxidant activities on the skin. It actively supports tissue regeneration through promoting fibroblast proliferation, enhancing collagen synthesis, and accelerating re-epithelialization, thereby contributing to wound healing. Furthermore, its natural mucilage content offers moisturizing properties that can help to calm skin irritation.
Research
Clinical Evidence
Medium confidence10%
Key findings
- 01 An ethanolic extract ointment containing 10% Sida cordifolia was found to effectively stimulate wound contraction and enhance epithelialization in rat models, indicating its potential for wound healing.
- 02 Topical application of Sida cordifolia extracts has been observed to promote the proliferation of fibroblasts, enhance collagen synthesis, and accelerate re-epithelialization, contributing to more rapid and complete wound closure.
Transparency
Dusting Analysis
Given the US FDA's ban on Sida cordifolia products due to serious safety concerns related to its ephedrine-type alkaloid content, any inclusion in cosmetic formulations, particularly above a non-detectable threshold, presents a significant red flag. The documented maximum concentration of 0% implies that any purported efficacy at this level for a precision brand like Moumoujus would be considered problematic.
The Formula
Formulation
Conflicts
- Cardiac glycosides (caution for topical use if systemic absorption is a concern, though primarily noted for internal use).
- Monoamine oxidase inhibitors (MAOIs) (caution for topical use if systemic absorption is a concern, though primarily noted for internal use).
- Ergot alkaloids (caution for topical use if systemic absorption is a concern, though primarily noted for internal use).
- Caffeine (fatal in combination with ephedrine for internal consumption; highlights the severe risks of systemic exposure).
Safety
Safety Profile
The US Food and Drug Administration (FDA) banned the sale of Sida cordifolia and products containing ephedrine in April 2004 due to serious safety concerns, including risks of high blood pressure, heart attacks, loss of consciousness, and death. Sida cordifolia contains ephedrine-type alkaloids. While topical application may reduce systemic exposure compared to internal consumption, the presence of these compounds and the 0% maximum concentration advise extreme caution, making it unsuitable for precision skincare formulations due to regulatory and health risks.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite some topical benefits observed in studies and its traditional use, Sida Cordifolia Root Powder contains ephedrine-type alkaloids, leading to a US FDA ban and a maximum concentration of 0%, rendering it an unacceptable ingredient for safe and compliant precision skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…